Elaborating a bit further on M-M trial: Clinica
Post# of 148172
(Total Views: 627)
Posted On: 05/13/2020 5:06:37 PM
Elaborating a bit further on M-M trial:
Clinical Improvement as assessed by change in total symptom score (for fever, myalgia, dyspnea and cough) [ Time Frame: Day 14 ]
We should do well in Mild-Moderate (primary outcomes) trial as:
Fever: Body will recover immunological functionality and fever will go down gradually. Once body recovers in few days fever, hallas, will be gone.
Myalgia: If the viral load diminishes the myalgia will come down as a consequence (being a viral myalgia)
Dyspnea: As the cytokine storm is quelled the dyspnea will go away rapidly, we have seen this already with intubated patients (severe).
Cough: Well, the body will heal, immunological function restores and cough will alleviate.
In conclusion: As per Dr. Patterson data, we should have very good results from this trial. The p-value should be "in the floor".
Clinical Improvement as assessed by change in total symptom score (for fever, myalgia, dyspnea and cough) [ Time Frame: Day 14 ]
We should do well in Mild-Moderate (primary outcomes) trial as:
Fever: Body will recover immunological functionality and fever will go down gradually. Once body recovers in few days fever, hallas, will be gone.
Myalgia: If the viral load diminishes the myalgia will come down as a consequence (being a viral myalgia)
Dyspnea: As the cytokine storm is quelled the dyspnea will go away rapidly, we have seen this already with intubated patients (severe).
Cough: Well, the body will heal, immunological function restores and cough will alleviate.
In conclusion: As per Dr. Patterson data, we should have very good results from this trial. The p-value should be "in the floor".
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼